FAQ/Help |
Calendar |
Search |
Today's Posts |
03-05-2012, 03:06 PM | #1 | |||
|
||||
Senior Member
|
Glutamate NMDA receptor dysregulation in Parkinson’s disease with dyskinesias
Ahmed I et al. – These findings are consistent indicating that increased glutamatergic activity is implicated in the development and maintenance of levodopa–induced dyskinesias. They support the hypothesis that blockade of glutamate transmission may have a place in the management of disabling dyskinesias in Parkinson's disease http://brain.oxfordjournals.org/cont...in.awr028.full
__________________
In the last analysis, we see only what we are ready to see, what we have been taught to see. We eliminate and ignore everything that is not a part of our prejudices. ~ Jean-Martin Charcot The future is already here — it's just not very evenly distributed. William Gibson |
|||
Reply With Quote |
03-05-2012, 03:20 PM | #2 | ||
|
|||
In Remembrance
|
__________________
paula "Time is not neutral for those who have pd or for those who will get it." |
||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
Glutamate identified as predictor of disease progression in multiple sclerosis (Topix | Multiple Sclerosis | |||
Cough suppressant may treat dyskinesias in Parkinson's patients | Parkinson's Disease |